<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05109377</url>
  </required_header>
  <id_info>
    <org_study_id>E-93471371-514.10</org_study_id>
    <nct_id>NCT05109377</nct_id>
  </id_info>
  <brief_title>Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment</brief_title>
  <official_title>Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both&#xD;
      before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile&#xD;
      dysfunction severity and tadalafil treatment relations with endocen level.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will include at least 90 patients in study. Blood tests will taken before&#xD;
      and after tadalafil treatment and will store at -80 celcius degree.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 24, 2021</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rates of IIEF Score</measure>
    <time_frame>1 month</time_frame>
    <description>Levels of Endocan relationship with IIEF</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Levels of Endocan</measure>
    <time_frame>1 month</time_frame>
    <description>Levels of Endocan with tadalafil treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>5mg tadalafil</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>5mg tadalafil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20mg tadalafil</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>20 mg tadalafil</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Endocan</intervention_name>
    <description>Endocan will measured before and after treatment</description>
    <arm_group_label>20mg tadalafil</arm_group_label>
    <arm_group_label>5mg tadalafil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tadalafil</intervention_name>
    <description>tadalafil</description>
    <arm_group_label>20mg tadalafil</arm_group_label>
    <arm_group_label>5mg tadalafil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        • Patients with erectile dysfuction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Psychogenic erectile dysfunction&#xD;
&#xD;
          -  Erectile dysfunction associated with hormonal disorders&#xD;
&#xD;
          -  Drug related erectile dysfunction&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Veysel Bayburtluoğlu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veysel Bayburtluoğlu</last_name>
    <phone>+905530299981</phone>
    <email>bayburtluogluveysel@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Veysel Bayburtluoğlu</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veysel Bayburtluoğlu</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 4, 2021</study_first_submitted>
  <study_first_submitted_qc>November 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Veysel Bayburtluoğlu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Endocan</keyword>
  <keyword>Erectile dysfunction</keyword>
  <keyword>Tadalafil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tadalafil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Research data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

